A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
Conditions
Neuromyelitis Optica Spectrum Disorder · NMOSD
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Children's Hospital Colorado., Denver, Colorado, United States
Hospital de Pediatría S.A.M.I.C.- Prof. Dr. Juan P. Garrahan, Ciudad Autonoma Buenos Aires, Argentina
Clinica Universitaria Reina Fabiola, Córdoba, Argentina
Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China
Children's Hospital of Fudan University, Shanghai, Shanghai Municipality, China
Centre Hospitalier Universitaire de Bicêtre, Le Kremlin-Bicêtre, France
IRCCS Ospedale Pediatrico Bambino Gesù - INCIPIT - PIN, Rome, Lazio, Italy
Fondazione Istituto Neurologico Mondino IRCCS, Pavia, Lombardy, Italy
Grupo Medico Camino, DF, Mexico CITY (federal District), Mexico
Uniwersyteckie Centrum Kliniczne, Gdansk, Poland
Instytut "Pomnik - Centrum Zdrowia Dziecka", Warsaw, Poland
Kocaeli University Research and Application Hospit, Kocaeli, Turkey (Türkiye)
Great Ormond Street Hospital for Children, London, United Kingdom
Study leads
Clinical Trials
Study Director
Hoffmann-La Roche